Trial intelligence / Profile preview

Pravastatin Effect on Erythrocyte Membrane Fatty Acids in CKD

NCT02992548Phase 4Completed

Sponsor
Dong-A University
Start
Sep 2015
Primary completion
Dec 2018
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of pravastatin in chronic kidney disease (CKD), sponsored by Dong-A University. Started Sep 2015; status: completed.

02

Drugs

pravastatin
03

Conditions

chronic kidney disease (CKD)

Beyond the preview

Go deeper on NCT02992548.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02992548.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call